Top Markets
Coin of the day
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Kedudukan dalam Saham #16422
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Harga Saham
$4.64
Disegerakkan terakhir: 2022-09-12
Modal Pasaran
$293.43M
Perubahan (1 hari)
0.87%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Adagio Therapeutics, Inc. (ADGI)

Kategori

Sejarah pecahan saham untuk Adagio Therapeutics, Inc. (ADGI)
Saham Adagio Therapeutics, Inc. (simbol: ADGI) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Sep 02, 2026.
Satu saham ADGI yang dibeli sebelum Sep 02, 2026 kini bersamaan dengan 0 saham ADGI.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH